Neogen (NEOG) Other Non-Current Assets (2011 - 2026)
Neogen (NEOG) recorded quarterly Other Non-Current Assets of $31.8 million in Q1 2026, down 98.7% quarter-over-quarter from $2.5 billion in Q4 2025, and up 11.47% on a YoY basis from $28.5 million in Q1 2025.
Neogen (NEOG) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Neogen's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $31.8 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 11.47% year-over-year to $31.8 million; the TTM figure through Feb 2026 stood at $31.8 million (up 11.47% YoY), while the FY2025 annual figure was $35.2 million, up 203.21% from the prior year.
- Other Non-Current Assets was $31.8 million for Q1 2026 at Neogen, down from $2.5 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.5 billion in Q3 2025 to a low of $2.0 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $320.2 million across 5 years, with a median of $16.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets sank 94.3% in 2023, then surged 12443.52% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $3.9 million in 2022, then soared by 309.73% to $16.0 million in 2023, then climbed by 26.42% to $20.2 million in 2024, then surged by 12026.83% to $2.5 billion in 2025, then tumbled by 98.7% to $31.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $31.8 million (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 31.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 31.80 Mn |
| Nov 30, 2025 | 2.45 Bn |
| Aug 31, 2025 | 2.51 Bn |
| May 31, 2025 | 35.20 Mn |
| Feb 28, 2025 | 28.53 Mn |
| Nov 30, 2024 | 20.23 Mn |
| Aug 31, 2024 | 20.00 Mn |
| May 31, 2024 | 11.61 Mn |
| Feb 29, 2024 | 12.35 Mn |
| Nov 30, 2023 | 16.00 Mn |
| Aug 31, 2023 | 13.82 Mn |
| May 31, 2023 | 14.56 Mn |
| Feb 28, 2023 | 15.30 Mn |
| Nov 30, 2022 | 3.91 Mn |
| Aug 31, 2022 | 2.16 Mn |
| May 31, 2022 | 255.55 Mn |
| Feb 28, 2022 | 2.02 Mn |
| Nov 30, 2021 | 2.02 Mn |
| Aug 31, 2021 | 2.02 Mn |
| May 31, 2021 | 228.29 Mn |